SELE Human, HEK

E-Selectin Human Recombinant, HEK
Shipped with Ice Packs
In Stock

Description

Production in HEK293 Systems

HEK293 cells are preferred for SELE production due to their ability to perform human-like post-translational modifications and high yield capabilities .

Key Advantages of HEK293:

  • Glycosylation Fidelity: Produces sialylated and fucosylated structures matching endogenous human E-Selectin .

  • High Titers: Fed-batch bioreactors achieve yields >696 mg/L for complex proteins .

  • Regulatory Compliance: HEK293-derived biologics have FDA/EMA approval precedents (e.g., Dulaglutide) .

Production Protocol:

  1. Transfection: Vectors with human GLUL selection markers enable stable integration .

  2. Purification: Proprietary chromatographic techniques yield >95% purity (SDS-PAGE) .

  3. Formulation: Lyophilized in PBS + 4% mannitol (pH 7.4–7.5) for stability .

Functional and Research Applications

SELE Human, HEK is utilized in:

  • Leukocyte Adhesion Studies: Binds sialylated ligands on neutrophils/monocytes under shear stress .

  • Inflammation Modeling: Transient endothelial expression peaks at 4 hours post-cytokine activation (IL-1β/TNF-α) .

  • Therapeutic Development: Used to screen inhibitors of chronic inflammatory diseases .

Quality Control Metrics

Critical parameters for batch consistency:

ParameterSpecificationMethod
Purity>95%SDS-PAGE
Endotoxin Levels<1.0 EU/µg (implied by sterile filtration)Not specified
Stability (Lyophilized)3 weeks at RT; long-term at ≤-18°C
Reconstitution≥100 µg/mL in PBS

Limitations and Considerations

  • Cost: HEK293-derived SELE is ~30% more expensive than CHO cell-produced equivalents due to higher cultivation costs .

  • Batch Variability: Glycosylation patterns may differ slightly between HEK293 subclones .

Product Specs

Introduction
E-selectin, also known as Endothelial leukocyte adhesion molecule 1 (ELAM1 or ELAM), is a member of the selectin family of adhesion molecules. These molecules are divalent cation-dependent carbohydrate-binding glycoproteins. E-selectin is expressed on the surface of endothelial cells, where it mediates the binding of leukocytes and platelets during inflammatory responses. The human E-selectin gene contains 14 exons and spans approximately 13 kb of DNA.
Description
Recombinant human SELE protein, expressed in a mammalian system using human cells, is a single polypeptide chain consisting of 543 amino acids (residues 22-556). The protein includes an 8 amino acid His-tag fused to the C-terminus and is purified using proprietary chromatographic techniques.
Physical Appearance
Sterile, white lyophilized (freeze-dried) powder.
Formulation
The SELE protein was lyophilized from a 0.2 µM filtered solution containing PBS and 4% Mannitol at pH 7.5.
Solubility
To reconstitute the lyophilized SELE protein, it is recommended to dissolve it in 1xPBS to a minimum concentration of 100 µg/ml. This solution can then be further diluted with other aqueous solutions.
Stability
Lyophilized SELE protein remains stable at room temperature for up to 3 weeks. However, for long-term storage, it should be stored desiccated at temperatures below -18°C. Once reconstituted, the SELE protein should be stored at 4°C for up to 7 days. For extended storage, it should be kept at -18°C. Repeated freeze-thaw cycles should be avoided.
Purity
The purity of the protein is determined to be greater than 95% by SDS-PAGE analysis.
Synonyms
E-selectin, Endothelial leukocyte adhesion molecule 1, ELAM-1, Leukocyte-endothelial cell adhesion molecule 2, LECAM2, CD62E antigen, SELE, ELAM1, ELAM, ESEL, CD62E.
Source
HEK293 cells.
Amino Acid Sequence
WSYNTSTEAMTYDEASAYCQQRYTHLVAIQNKEEIEYLNSILSYSPSYYWIGIRKVNNVW
VWVGTQKPLTEEAKNWAPGEPNNRQKDEDCVEIYIKREKDVGMWNDERCSKKKLALCYTA
ACTNTSCSGHGECVETINNYTCKCDPGFSGLKCEQIVNCTALESPEHGSLVCSHPLGNFSY
NSSCSISCDRGYLPSSMETMQCMSSGEWSAPIPACNVVECDAVTNPANGFVECFQNPGSFPW
NTTCTFDCEEGFELMGAQSLQCTSSGNWDNEKPTCKAVTCRAVRQPQNGSVRCSHSPAGEFT
FKSSCNFTCEEGFMLQGPAQVECTTQGQWTQQIPVCEAFQCTALSNPERGYMNCLPSASGSFR
YGSSCEFSCEQGFVLKGSKRLQCGPTGEWDNEKPTCEAVRCDAVHQPPKGLVRCAHSPIGEFTY
KSSCAFSCEEGFELHGSTQLECTSQGQWTEEVPSCQVVKCSSLAVPGKINMSCSGEPVFGTVCKF
ACPEGWTLNGSAARTCGATGHWSGLLPTCEAPTESNIPVDHHHHHH.

Q&A

What is SELE and why is it significant for research using HEK293 cells?

SELE, also known as E-selectin, Endothelial leukocyte adhesion molecule 1 (ELAM-1), or CD62E, belongs to a family of divalent cation-dependent carbohydrate-binding glycoproteins or adhesion molecules. It is naturally expressed on the surface of endothelial cells and mediates the interaction of leukocytes and platelets with endothelial cells during inflammatory responses . SELE is present in single copy in the human genome and contains 14 exons spanning approximately 13 kb of DNA .

The significance of expressing SELE in HEK293 cells stems from the cell line's human origin, which ensures proper post-translational modifications crucial for SELE function. HEK293 cells implement humanized glycosylation patterns that avoid potentially immunogenic non-human modifications like α-gal and NGNA that can be introduced by non-human cell lines such as CHO . Additionally, HEK293 cells have been shown to be especially efficient in specific modifications like tyrosine sulfation and glutamic acid γ-carboxylation, which may be relevant for proper SELE folding and function .

Why choose HEK293 cells over other expression systems for SELE production?

HEK293 cells offer several distinct advantages for SELE production compared to other expression systems:

  • Human post-translational modifications: As a human cell line, HEK293 produces proteins with native human glycosylation patterns and other post-translational modifications, which is critical for functional studies of human proteins like SELE .

  • Growth characteristics: HEK293 cells can grow in suspension in serum-free media, enabling large-scale production with reproducibility across different batches, which is essential for consistent experimental results .

  • Transfection efficiency: These cells are highly amenable to different transfection methods and demonstrate high efficiency of protein production, making them ideal for both transient and stable expression of complex glycoproteins like SELE .

  • Regulatory acceptance: Several therapeutic proteins produced in HEK293 cells have been approved by regulatory agencies for human use, establishing a precedent for their use in producing biotherapeutics that may eventually have translational potential .

  • Scalability: The adaptability of HEK293 cells to various culture conditions allows researchers to scale from small analytical batches to larger production runs without significantly altering protein characteristics .

What expression formats are available for SELE in HEK293 systems?

Expression FormatDescriptionAdvantagesLimitationsApplications
Full-length membrane-boundComplete SELE protein with transmembrane domainNative presentation; suitable for cell-based assaysRequires cell lysis for purificationCell adhesion studies; receptor clustering analysis
Soluble extracellular domainSELE lacking transmembrane and cytoplasmic domainsEasier purification; solution-phase applicationsMay lack native clustering effectsBinding affinity measurements; structural studies
Fc fusionSELE extracellular domain fused to antibody Fc regionEnhanced stability; easy purification via Protein A/GForced dimerization; bulky tagIncreased avidity; extended half-life in vivo
His-tagged variantsSELE with polyhistidine tag (typically C-terminal)Simple IMAC purification; minimal tag sizeMay affect function if near binding sitePurification; immobilization for binding studies
Fluorescent protein fusionsSELE fused to GFP, mCherry, etc.Direct visualization; trafficking studiesLarge tag may interfere with functionLive-cell imaging; BiFC interaction studies

For recombinant SELE production in HEK293 cells, the protein is typically expressed as a single polypeptide chain containing 543 amino acids (residues 22-556) with a C-terminal His-tag for purification purposes . This format facilitates straightforward purification while maintaining the functional domains necessary for SELE's carbohydrate-binding activities.

How does the CRISPR/Cas9 system enhance SELE research in HEK293 cells?

The CRISPR/Cas9 system has revolutionized genomic engineering in higher organisms, including human cell lines like HEK293 . For SELE research, this technology offers multiple methodological advantages:

  • Endogenous tagging: CRISPR/Cas9 enables precise insertion of affinity or fluorescent tags at the genomic SELE locus, allowing studies of the endogenous protein rather than relying on overexpression systems . This preserves native expression levels and regulatory mechanisms.

  • Functional genomics: The system facilitates knockout or knockdown of SELE or related genes to study loss-of-function phenotypes. Similarly, specific mutations can be introduced to investigate structure-function relationships.

  • Reporter cell line generation: CRISPR/Cas9 can be used to create HEK293 reporter cells where fluorescent or enzymatic reporters are driven by the endogenous SELE promoter, allowing studies of SELE regulation in response to various stimuli.

  • Multiplex modifications: Multiple genomic sites can be targeted simultaneously, enabling complex genetic modifications such as humanizing glycosylation pathways while expressing SELE.

The efficiency of this system has been demonstrated in HEK293T cells, making it a powerful approach for generating physiologically relevant models for studying SELE biology .

What are optimal conditions for expressing recombinant SELE in HEK293 cells?

Achieving optimal SELE expression in HEK293 cells requires careful consideration of multiple parameters:

  • Culture medium composition: DMEM containing 4.5 g/l glucose supplemented with 2 mM L-glutamine provides essential nutrients for robust cell growth and protein production . For maintenance, 10% fetal bovine serum is typically used, though serum-free formulations are available for production phases .

  • Antibiotic selection: For stable cell lines, appropriate selection antibiotics must be maintained. Common selections for HEK293 expression systems include blasticidin, hygromycin, and Zeocin® at empirically determined concentrations .

  • Culture conditions: Cells should be maintained at 37°C in a humidified atmosphere with 5% CO2 . For suspension culture, maintaining cell density between 0.5-3 × 10^6 cells/ml is crucial for optimal growth and expression.

  • Transfection optimization: For transient expression, optimizing the DNA:transfection reagent ratio is essential. Polyethylenimine (PEI) offers cost-effective transfection with high efficiency in HEK293 cells.

  • Expression timing: Optimal protein collection typically occurs 48-96 hours post-transfection for transient systems, with peak expression often observed around 72 hours.

  • Mycoplasma testing: Regular testing ensures cultures remain mycoplasma-free, as contamination can significantly impact cell performance and protein production .

What purification strategies are most effective for SELE from HEK293 expression?

The purification of SELE from HEK293 cell culture typically involves a multi-step process:

  • Initial capture: For His-tagged SELE (as described in search result ), immobilized metal affinity chromatography (IMAC) using Ni-NTA resin provides an efficient first purification step. The typical buffer contains PBS with an imidazole gradient for elution .

  • Buffer formulation: After purification, SELE is typically stored in PBS containing 4% mannitol at pH 7.5, which helps maintain protein stability during freeze-drying and subsequent reconstitution .

  • Quality control: Following purification, SDS-PAGE analysis should confirm >95% purity, as specified for commercial preparations . Western blotting using anti-SELE antibodies can verify identity.

  • Storage recommendations: Lyophilized SELE demonstrates stability at room temperature for up to 3 weeks but should be stored desiccated below -18°C for long-term preservation. After reconstitution, the protein should be stored at 4°C if used within 2-7 days, or below -18°C for future use. Multiple freeze-thaw cycles should be avoided to preserve functional integrity .

How can Cell-PCA be applied to study SELE protein interactions?

Cell-based Protein Complementation Assay (Cell-PCA) offers a powerful approach to study SELE interactions with potential binding partners in living cells:

  • Experimental principle: Cell-PCA utilizes bimolecular fluorescence complementation (BiFC), where a fluorescent protein is split into non-fluorescent fragments. When SELE and an interaction partner each fused to complementary fragments come into proximity, fluorescence is reconstituted, indicating protein interaction .

  • Implementation strategy: For studying SELE interactions:

    • Fuse SELE to one fragment (e.g., VN, the N-terminal fragment of Venus fluorescent protein)

    • Create libraries of potential interaction partners fused to the complementary fragment (CC)

    • Express these constructs in HEK293 cells

    • Detect interactions through fluorescence microscopy

  • Advantages for SELE research: This method allows visualization of interactions in living cells, maintaining the native membrane environment critical for SELE function. It also enables high-throughput screening of potential interactors from ORFeome libraries .

  • Validation approach: As demonstrated with HOX protein interactions, positive interactions identified through Cell-PCA should be validated through individual BiFC experiments and orthogonal methods like co-immunoprecipitation .

This technique has proven valuable for comparing interactomes of related proteins in the same cellular context, making it ideal for studying differential interaction patterns of SELE compared to other selectin family members .

What considerations are important when designing a reporter cell system using HEK293 for SELE studies?

When developing HEK293-based reporter systems for SELE research, several methodological considerations are crucial:

  • Reporter selection: For NF-κB pathway activation studies, secreted embryonic alkaline phosphatase (SEAP) provides a reliable, non-destructive readout that can be measured in real-time using specialized detection media .

  • Integration strategy: The reporter gene (e.g., SEAP) should be placed under control of a relevant promoter, such as the IFN-β minimal promoter fused to NF-κB and AP-1-binding sites for inflammatory signaling pathways .

  • Co-receptor considerations: For optimal SELE-related signaling, co-transfection of relevant co-receptors may be necessary. For example, the CD14 co-receptor enhances TLR2 responses in HEK-Blue hTLR2 cells, which could be adapted for SELE studies .

  • Selection markers: Multiple antibiotic resistance genes (blasticidin, hygromycin, Zeocin®) allow for selection and maintenance of stable transfectants .

  • Control cell lines: Appropriate parental cell lines (e.g., HEK-Blue Null1 cells) should be maintained as controls .

  • Validation: Reporter activation should be calibrated using known stimuli or ligands at established concentrations, ensuring a reproducible dose-response relationship.

This approach has been successfully implemented for TLR2 studies in HEK293 cells and could be adapted to investigate SELE-mediated signaling or to screen for compounds that modulate SELE expression or function .

What imaging approaches are most effective for studying SELE trafficking in HEK293 cells?

Advanced imaging of SELE in HEK293 cells requires techniques that balance resolution, sensitivity, and physiological relevance:

  • Endogenous tagging strategy: CRISPR/Cas9 genome engineering offers a powerful approach for inserting fluorescent tags at the endogenous SELE locus, allowing visualization of the protein under native expression conditions . This avoids artifacts associated with overexpression systems.

  • Live cell applications: For tracking SELE dynamics, spinning disk confocal microscopy provides rapid acquisition with reduced phototoxicity. Total Internal Reflection Fluorescence (TIRF) microscopy is particularly valuable for selectively visualizing cell surface events, which is critical for studying SELE's membrane presentation.

  • Co-localization studies: Multi-color imaging with markers for various cellular compartments (endosomes, Golgi, ER) helps determine SELE's trafficking pathway. Quantitative co-localization analysis using Pearson's or Manders' coefficients provides objective measures of association.

  • Functional imaging approaches: Fluorescence Recovery After Photobleaching (FRAP) can measure SELE mobility in membranes, while photoactivatable or photoconvertible fluorophores allow pulse-chase experiments to track protein cohorts over time.

  • Super-resolution options: For detailed analysis of SELE clustering or nanoscale organization, techniques like Stimulated Emission Depletion (STED) microscopy or Stochastic Optical Reconstruction Microscopy (STORM) overcome the diffraction limit of conventional microscopy.

Each approach offers complementary information about SELE biology, and the choice depends on the specific research question being addressed.

How can BiFC be optimized for studying SELE interactions with other proteins?

Bimolecular Fluorescence Complementation (BiFC) offers a powerful approach for visualizing SELE interactions in living cells, but requires careful optimization:

  • Construct design considerations:

    • For membrane-bound SELE, typically C-terminal fusion of the fluorescent protein fragment works best to avoid interfering with the signal peptide.

    • Flexible linkers (GGGGS repeats) between SELE and the fluorescent protein fragment help reduce steric hindrance.

    • Both split-Venus and split-mCherry systems can be effective, with Venus offering brighter signal but faster maturation with mCherry allowing for temporal control.

  • Expression level optimization: The BiFC system used in Cell-PCA typically works best with basal expression levels rather than overexpression, as this maintains physiological relevance and reduces background . Transfection conditions should be optimized accordingly.

  • Imaging parameters: When conducting BiFC analysis, imaging parameters should be calibrated using known interaction partners as positive controls . This standardization allows for statistical significance assessment across biological replicates.

  • Validation approach: As demonstrated with HOX protein interactions, positive interactions identified through BiFC should be confirmed through orthogonal experimental approaches like co-immunoprecipitation .

  • Analysis considerations: BiFC can reveal various interaction profiles in live cells, with differences in subcellular localization or signal intensity providing additional biological information beyond simple binary interaction data .

This technique has proven particularly valuable for comparing interactomes of related proteins in the same cellular context, making it ideal for studying differential interaction patterns of SELE compared to other selectin family members .

What analytical methods best characterize SELE glycosylation when expressed in HEK293 cells?

Characterizing SELE glycosylation requires a multi-faceted analytical approach:

  • Glycosidase treatment analysis:

    • PNGase F digestion to remove N-linked glycans

    • Endoglycosidase H to distinguish high-mannose from complex glycans

    • O-glycosidase treatment for O-linked glycan assessment

    • Analysis via SDS-PAGE mobility shift provides initial glycosylation status

  • Mass spectrometry approaches:

    • Glycopeptide analysis using electron transfer dissociation (ETD) preserves glycan attachment site information

    • MALDI-TOF analysis of released glycans provides glycan profile fingerprints

    • Tandem MS with multiple fragmentation techniques allows detailed glycan structure determination

  • Lectin-based methods:

    • Lectin blotting with specific lectins (e.g., SNA for α2,6-sialic acids)

    • Lectin affinity chromatography for glycoform enrichment

    • Lectin microarrays for high-throughput glycan profiling

  • Functional glycan analysis:

    • Glycan array screening to identify binding preferences

    • Surface plasmon resonance with defined glycoconjugates

    • Cell-based assays comparing wild-type and glycosylation-modified SELE

These methods provide complementary information about SELE glycosylation patterns, which are critical for its proper folding, trafficking, and functional activity as an adhesion molecule.

What approaches can distinguish between specific and non-specific interactions in SELE studies?

Distinguishing genuine SELE interactions from experimental artifacts requires multiple methodological controls:

  • Cell-PCA implementation strategy: When using Cell-PCA for interactome analysis, performing screens in duplicate cell lines (e.g., CC-HEK-1 and CC-HEK-2) provides biological replicates that increase confidence in reproducible interactions . Interactions that appear in both cell lines are more likely to be genuine.

  • Statistical filtering: Applying appropriate threshold criteria is essential for selecting positive interactions from high-throughput screens. The filtering approach should be validated against known interactions .

  • Validation sequence: Candidate interactions should be confirmed through:

    • Individual BiFC experiments with appropriate controls

    • Orthogonal methods like co-immunoprecipitation

    • Functional assays testing biological relevance

  • Controls for binding specificity:

    • Competitive inhibition with soluble ligands

    • Mutational analysis of putative binding interfaces

    • Domain deletion to map interaction regions

    • Use of blocking antibodies against specific epitopes

  • Signal calibration: When conducting BiFC analysis, imaging parameters should be calibrated using known interaction partners (e.g., PBX1 was used as a calibrator for HOXA9 studies) . This standardization allows for statistical significance assessment across biological replicates.

This systematic approach has been successfully applied to HOX protein interaction studies and can be adapted for rigorous analysis of SELE interactions .

What are common challenges in achieving high SELE expression in HEK293 cells and how can they be addressed?

Several challenges can limit SELE expression in HEK293 cells, each requiring specific optimization strategies:

  • Low transfection efficiency:

    • Optimize DNA:transfection reagent ratios through systematic testing

    • Ensure high-quality plasmid DNA (A260/280 > 1.8)

    • Consider nucleofection for difficult constructs

    • Test multiple transfection reagents (PEI, lipid-based, calcium phosphate)

  • Poor protein folding and secretion:

    • Implement temperature shifts (37°C to 30-32°C) after initial growth phase

    • Add chemical chaperones (e.g., 4-PBA, DMSO, glycerol) to culture media

    • Optimize signal peptide sequence or use a high-efficiency secretion signal

    • Co-express folding chaperones (BiP, PDI, calnexin)

  • Protein degradation:

    • Add protease inhibitors to culture media

    • Modify culture pH (typically 7.0-7.2) to optimize stability

    • Reduce culture temperature to slow degradation

    • Consider fusion tags that enhance stability (Fc, albumin)

  • Cell viability issues:

    • Monitor and optimize cell density (typically 0.5-3 × 10^6 cells/ml)

    • Regular testing to ensure cultures remain mycoplasma-free

    • Implement fed-batch strategies to prevent nutrient depletion

    • Use high-quality serum or serum-free media optimized for HEK293 cells

  • Glycosylation heterogeneity:

    • Consider GlycoDelete HEK293 cells for simplified glycosylation

    • Supplement media with specific monosaccharides

    • Optimize glucose concentration and feeding strategy

    • Consider copper and manganese supplementation for glycosyltransferase activity

These optimization strategies can significantly improve SELE expression quality and quantity, enhancing downstream applications and experimental reproducibility.

How can researchers validate that SELE produced in HEK293 cells retains proper functionality?

Validating the functional integrity of SELE produced in HEK293 cells requires multiple complementary approaches:

  • Structural integrity assessment:

    • SDS-PAGE under reducing and non-reducing conditions to confirm molecular weight and disulfide bond formation

    • Western blot using conformation-specific antibodies

    • Thermal shift assays to evaluate protein stability compared to reference standards

  • Glycosylation analysis:

    • PNGase F or Endo H digestion followed by SDS-PAGE to assess glycosylation status

    • Lectin binding assays to characterize specific glycan structures

    • Mass spectrometry to verify the presence of critical modifications

  • Binding assays:

    • Solid-phase binding to known SELE ligands (e.g., sialyl Lewis X)

    • Surface plasmon resonance (SPR) to determine binding kinetics and affinity constants

    • Cell adhesion assays using leukocytes or cell lines expressing SELE ligands

  • Functional cell-based assays:

    • Static adhesion assays with appropriate leukocyte populations

    • Flow-based assays to assess SELE-mediated leukocyte rolling

    • Calcium dependency tests (SELE binding requires calcium ions)

    • Competitive inhibition with known SELE blockers

  • Comparative analysis:

    • Side-by-side comparison with commercially validated SELE standards

    • Benchmark against native SELE isolated from activated endothelial cells

    • Evaluation against published parameters for binding constants and specificity

These validation steps ensure that SELE produced in HEK293 cells maintains the structural and functional characteristics necessary for meaningful experimental applications.

What strategies can overcome glycosylation heterogeneity in SELE expressed in HEK293 cells?

Glycosylation heterogeneity can pose challenges for consistent SELE production in HEK293 cells. Several strategies can address this issue:

  • Cell line engineering approaches:

    • Use GlycoDelete HEK293 cells, which have modified glycosylation pathways producing simpler, more homogeneous glycans

    • Engineer cells to overexpress specific glycosyltransferases relevant to SELE function

    • Consider knockout of fucosyltransferases or other enzymes if specific glycan modifications are problematic

    • Implement HEK293S GnTI- cells for high-mannose glycosylation when homogeneity is critical

  • Culture optimization:

    • Maintain tight control of glucose concentration, as glucose availability affects glycosylation patterns

    • Supplement media with manganese to enhance glycosyltransferase activity

    • Implement fed-batch strategies with controlled nutrient addition

    • Consider copper supplementation, which influences glycosylation machinery

  • Process engineering:

    • Decrease culture temperature to 32°C, which often improves glycosylation quality and homogeneity

    • Maintain pH within narrow bounds (typically 7.0-7.2) for optimal glycosyltransferase activity

    • Consider mild osmolality shifts, which can influence glycosylation patterns

    • Implement controlled feeding strategies to maintain consistent glycosylation substrates

  • Post-production approaches:

    • Use endoglycosidases to trim heterogeneous glycans to a common core

    • Apply lectin affinity chromatography to isolate desired glycoforms

    • Consider in vitro enzymatic remodeling to generate homogeneous glycoforms

    • Implement advanced analytical methods to characterize and select desired glycoforms

These strategies can significantly reduce glycosylation heterogeneity, improving batch-to-batch consistency and experimental reproducibility when working with SELE.

How should researchers approach unexpected results in SELE interaction studies?

When encountering unexpected results in SELE interaction studies, a systematic troubleshooting approach is essential:

  • Technical verification:

    • Confirm protein expression and localization through Western blotting and immunofluorescence

    • Verify assay functionality using well-established positive and negative controls

    • Ensure appropriate buffer conditions (particularly calcium concentration for SELE)

    • Check for batch effects in reagents or cell lines

  • Methodological considerations:

    • Compare results across multiple interaction detection methods (e.g., BiFC, co-IP, FRET)

    • In BiFC experiments, test both orientations of fluorescent protein fragments

    • Consider if the cellular context might affect interaction patterns

    • Evaluate whether tags or fusion proteins might interfere with interactions

  • Biological interpretation:

    • Consider whether the interaction might be context-dependent or stimulus-responsive

    • Evaluate whether post-translational modifications might regulate the interaction

    • Investigate if competing binding partners could influence results

    • Test interaction in multiple cell types if possible

  • Cell-PCA specific considerations:

    • For Cell-PCA approaches, remember that transduction with low MOI results in incomplete integration of the CC-ORFeome library in each cell line (around 70%)

    • Using two cell lines increases the proportion of the human ORFeome covered (reaching 82%)

    • Consider whether interactions specific to one cell line or common to both should be prioritized

    • Verify findings through individual BiFC with statistical analysis across biological replicates

  • Validation strategy:

    • Confirm key interactions through orthogonal methods like co-immunoprecipitation

    • Use domain mapping or mutagenesis to identify critical interaction interfaces

    • Test the functional relevance of interactions through knockdown or inhibition studies

This systematic approach helps distinguish genuine biological findings from technical artifacts in SELE interaction studies.

How might evolutionary considerations impact SELE research in human cell models?

Understanding the evolutionary context of SELE provides important perspective for human cell-based research:

  • Evolutionary conservation: While humans continue to evolve, the pace of biological change is extremely slow . Key immune molecules like SELE are under selective pressure, and their core functions are highly conserved. HEK293 cells thus provide a relevant model for studying fundamental SELE biology.

  • Human-specific features: Despite conservation of core function, species-specific differences in glycosylation patterns and fine regulation of expression exist. Human cell models like HEK293 capture these human-specific features, which may be missed in non-human expression systems .

  • Temporal considerations: Natural selection continues to operate on human populations, potentially selecting for variants that alter SELE function in response to changing pathogen pressures . Studies comparing SELE variants in HEK293 backgrounds could illuminate this ongoing evolution.

  • Cultural evolution effects: As noted by Sir David Attenborough, human evolution now occurs substantially through cultural rather than biological mechanisms . This raises interesting questions about how modern medical interventions might alter selective pressures on inflammatory response genes like SELE.

  • Experimental implications: The slow pace of human evolution suggests that findings from HEK293 cells are likely applicable across human populations, though population-specific variants should be considered when studying inflammatory disorders with ethnic disparities.

These evolutionary perspectives provide important context for interpreting SELE studies in human cell models and considering their broader biological significance.

What emerging technologies might enhance SELE research in HEK293 systems?

Several cutting-edge technologies show promise for advancing SELE research in HEK293 cells:

  • Next-generation CRISPR applications:

    • Base editing for precise nucleotide changes without double-strand breaks

    • Prime editing for targeted insertions and replacements

    • CRISPR activation/interference for modulating SELE expression without genetic modification

    • These approaches extend the efficient tagging capabilities demonstrated for endogenous proteins in HEK293T cells

  • Advanced cellular models:

    • Organoid systems incorporating HEK293-expressed SELE

    • Microfluidic "organ-on-chip" devices to study SELE under physiological flow

    • Co-culture systems combining HEK293-SELE cells with immune components

  • High-resolution structural techniques:

    • Cryo-electron microscopy of SELE in native membrane environments

    • In-cell NMR to study SELE dynamics in living HEK293 cells

    • Hydrogen-deuterium exchange mass spectrometry for conformational analysis

  • Single-cell approaches:

    • Single-cell proteomics to characterize cell-to-cell variation in SELE expression

    • Single-molecule imaging of SELE dynamics and clustering

    • Combined transcriptome/proteome analysis at single-cell level

  • Artificial intelligence applications:

    • Machine learning for image analysis of SELE trafficking

    • AI-driven prediction of SELE interaction networks

    • Computational design of modified SELE with enhanced properties

These emerging technologies promise to provide unprecedented insights into SELE biology and accelerate both basic research and therapeutic applications targeting this important adhesion molecule.

Product Science Overview

Structure and Properties

E-Selectin is a heavily glycosylated transmembrane protein. It consists of:

  • An N-terminal type 1 lectin domain
  • An EGF-like domain
  • Six sushi (CCP/SCR) domains
  • A transmembrane sequence
  • A short cytoplasmic domain

Recombinant human E-selectin is a 58.6kDa protein containing 535 amino acid residues, corresponding to the extracellular portion of the full-length protein. Due to glycosylation, E-selectin migrates at an apparent molecular weight of approximately 65-85kDa by SDS-PAGE analysis under reducing conditions .

Biological Function

E-Selectin plays a crucial role in the recruitment of circulating leukocytes from blood to sites of inflammation in the vascular lining through interaction with specific cell surface-associated carbohydrate determinants . It is a pro-angiogenic factor and has been implicated in the pathogenesis of stroke and atherosclerosis .

Expression and Production

The recombinant form of E-Selectin is expressed in HEK 293 cells. HEK (Human Embryonic Kidney) cells are commonly used for the production of recombinant proteins due to their high transfection efficiency and ability to perform post-translational modifications similar to those in human cells .

Applications

E-Selectin is used in various research applications, including:

  • Studying the mechanisms of leukocyte recruitment and inflammation
  • Investigating the role of E-Selectin in angiogenesis and vascular diseases
  • Developing therapeutic strategies targeting E-Selectin for inflammatory and cardiovascular diseases
Storage and Handling

Recombinant E-Selectin is typically lyophilized from a 0.22 μm filtered solution in PBS, pH 7.4, with mannitol or trehalose added as protectants before lyophilization. It should be reconstituted in sterile PBS, pH 7.4, to a concentration of 50 μg/mL and stored at 2-8°C for up to one month or at -20°C for extended storage .

E-Selectin is a vital molecule in the study of inflammation and vascular biology, providing insights into the mechanisms of leukocyte recruitment and the development of therapeutic interventions for related diseases.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.